New German healthcare reform law to significantly change pricing system
This article was originally published in SRA
Executive Summary
The lower house of the German parliament has passed a law reforming the market for medicinal products reimbursed by public health funds ("AMNOG") that will significantly change, and more or less end, free pricing of medicinal products by the pharmaceutical industry, among other things1.